Cencora COR Income Statement
| TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | ||
|---|---|---|---|---|---|---|
| $328.68B+0.9% | $325.78B+1.4% | $321.33B+1.5% | $316.65B+2.1% | $310.23B+2.3% | ||
| $316.16B+0.8% | $313.79B+1.3% | $309.85B+1.4% | $305.64B+2.0% | $299.71B+2.2% | ||
| $12.52B+4.4% | $11.99B+4.5% | $11.48B+4.2% | $11.02B+4.7% | $10.52B+5.2% | ||
| 3.8%+0.1pp | 3.7%+0.1pp | 3.6%+0.1pp | 3.5%+0.1pp | 3.4%+0.1pp | ||
| $7.19B+5.5% | $6.82B+5.0% | $6.49B+4.1% | $6.24B+4.9% | $5.95B+3.7% | ||
| $2.79B+4.0% | $2.68B+2.1% | $2.63B-4.0% | $2.74B+7.7% | $2.54B+23.5% | ||
| 0.8%0.0pp | 0.8%0.0pp | 0.8%0.0pp | 0.9%0.0pp | 0.8%+0.1pp | ||
| $1.09B+448,553% | -$243K+99.7% | -$78.72M— | —— | —— | ||
| $3.69B+45.8% | $2.53B+3.6% | $2.45B-4.9% | $2.57B+11.6% | $2.3B+25.1% | ||
| $954.11M+35.1% | $706.31M+2.3% | $690.52M+4.3% | $662.21M+11.0% | $596.42M+38.4% | ||
| —— | —— | —— | $1.9B+12.0% | $1.69B+21.3% | ||
| —— | —— | —— | $9.74+12.7% | $8.64+22.6% | ||
| $3.83B+2.8% | $3.72B+1.0% | $3.69B-3.3% | $3.81B+4.7% | $3.64B+14.7% | ||
| 1.2%0.0pp | 1.1%0.0pp | 1.1%-0.1pp | 1.2%0.0pp | 1.2%+0.1pp | ||
| $2.79B+4.0% | $2.68B+2.1% | $2.63B-4.0% | $2.74B+7.7% | $2.54B+23.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Cencora's revenue?
- Cencora (COR) generated $328.68B in revenue over the trailing twelve months, up 5.9% year over year.
- Is Cencora profitable?
- Cencora reported $3.6B in net income over the trailing twelve months, a 0.6% net margin.
- What are Cencora's profit margins?
- Gross margin is 3.8% and operating margin is 0.8%, with a 0.6% net margin.
- What is Cencora's earnings per share?
- Cencora's diluted EPS over the trailing twelve months is $18.47.
- Where does Cencora's income statement data come from?
- Every line is extracted from Cencora's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
